News

2026 05.28

Tigermed-Jyton Supports Approval of China's First 360-Degree Rotational Proton Therapy System

2026 05.25

Tigermed-Jyton Supports Approval of First PCL Product for Temporal Region

2026 05.25

Tigermed-Jyton Supports China NMPA Approval of Hi-Energy Ultrarapy™

2026 04.28

Officially Released！China’s First Group Standard for Injectable Collagen in Skin Quality Evaluation – Tigermed-Jyton as Key Developer

2026 04.03

Tigermed-Jyton supports China NMPA Approval of Retoxin® ——The World’s First Clinical Trial on Therapeutic Indication of Recombinant Botulinum Toxin Type A

2026 04.01

Tigermed-Jyton supports China NMPA Approval of Respacio® ——The First lsolation Hydrogel for Cervical Cancer Radiotherapy In The Word

2025 09.25

Tigermed-Jyton Supports the Multi-center Clinical Registration Study of the First Modular General Microsurgical Robot in China

2025 09.24

Womed Leaf, US’s First-in-Class degradable film for treating intrauterine adhesion received approval by FDA, Tigermed-Jyton CRO service made great contribution

2025 07.07

Tigermed Supports FDA Clearance of Fasikl’s Felix™ NeuroAI™ Wristband —the First AI-Powered Wearable Approved for Essential Tremor

2025 05.13

Tigermed-Jyton Supports the Approval of the First Hyaluronic Acid Sodium Composite Solution in the China Market.

Home Prev 1 2 Next End

Advance Human Health through
Delivery Excellence

Subscribe to Receive Tigermed-Jyton's Regulatory Newsletter

Obtain the latest industry and regulatory updates on a monthly basis.

Tel：+86-400-0739-391

Email：consult@tigermedgrp.com

Add：Suite 808, Union Plaza, Chaowai Street, Chaoyang District, Beijing

China Postal Code：100020

About us

Service & Tech

News

Contact Us

Copyright © 2017-2023 Tigermed-Jyton All Rights Reserved.

京ICP备2021039767号

Cookies

TOP

Cookies

The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.